Compare $ACXP vs $IMNN | Chartloom

Compare

$ACXP vs $IMNN

Acurx Pharmaceuticals Inc · Imunon Inc

ACXP

Acurx Pharmaceuticals Inc

IMNN

Imunon Inc

Compare $ACXP vs $IMNN

Comparing Acurx Pharmaceuticals Inc and Imunon Inc

ACXPAcurx Pharmaceuticals Inc

IMNNImunon Inc

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

IMNNImunon Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-72.7%

52W performance

-79.7%

FCF yield

-334.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

IMNN

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

IMNN

Imunon Inc

Market Cap

ACXP$5M

IMNN$5M

Enterprise Value

ACXP$-5M

IMNN$5M

Price

ACXP$1.27

IMNN$1.08

P/E Ratio

ACXPN/A

IMNNN/A

P/S Ratio

ACXP0.00x

IMNN13.81x

EV/Sales

ACXP0.00x

IMNN14.14x

EV/EBITDA

ACXP0.00x

IMNN0.00x

P/B Ratio

ACXP0.87x

IMNN1.71x

P/FCF Ratio

ACXPN/A

IMNNN/A

EV/FCF

ACXP0.84x

IMNN-0.31x

PEG Ratio

ACXPN/A

IMNNN/A

Forward P/E (NTM)

ACXPN/A

IMNNN/A

Forward P/S (NTM)

ACXPN/A

IMNNN/A

Revenue (TTM)

ACXP$0

IMNN$0

Revenue Growth (YoY)

ACXPN/A

IMNNN/A

Forward Rev Growth

ACXP40.7%

IMNN205.5%

Gross Margin (TTM)

ACXP0.0%

IMNN34.1%

Operating Margin (TTM)

ACXP0.0%

IMNN0.0%

EBITDA Margin (TTM)

ACXP0.0%

IMNN0.0%

Net Margin (TTM)

ACXP0.0%

IMNN0.0%

FCF Margin (TTM)

ACXPN/A

IMNNN/A

Net Income (TTM)

ACXP$-8M

IMNN$-15M

FCF (TTM)

ACXP$-6M

IMNN$-15M

EPS (TTM)

ACXP-$1.76

IMNN-$2.82

ROE (TTM)

ACXP-12474.0%

IMNN-31490.0%

ROA (TTM)

ACXP-8749.0%

IMNN-13292.0%

ROIC (TTM)

ACXP-12474.0%

IMNN-22880.0%

Cash

ACXP$11M

IMNN$7M

Debt

ACXP$0

IMNN$7M

Net Cash/Debt

ACXP$11M

IMNN$-170K

Current Ratio (TTM)

ACXP3.88x

IMNN1.82x

Quick Ratio (TTM)

ACXP3.80x

IMNN1.44x

Debt/Equity (TTM)

ACXP0.00x

IMNN1.68x

Debt/Assets (TTM)

ACXP0.0%

IMNN0.0%

Interest Coverage (TTM)

ACXPN/A

IMNNN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

IMNN0.00x

Beta

ACXP-2.14

IMNN2.08

52W Performance

ACXP-84.3%

IMNN-79.7%

YTD Performance

ACXP-54.0%

IMNN-72.7%

% from 52W High

ACXP-84.4%

IMNN-80.0%

% from 52W Low

ACXP3.3%

IMNN12.5%

Asset Turnover (TTM)

ACXP0.00x

IMNN0.01x

FCF Yield (TTM)

ACXP-113.2%

IMNN-334.7%

Earnings Yield (TTM)

ACXP-137.5%

IMNN-324.8%

Dividend Yield (TTM)

ACXPN/A

IMNNN/A

Rule of 40

ACXP0.0

IMNN0.0

EV/GP/RG

ACXPN/A

IMNNN/A

Ticker research

View ACXP research View IMNN research

Metric	ACXP Acurx Pharmaceuticals Inc	IMNN Imunon Inc
Market & Valuation
Market Cap	$5M	$5M
Enterprise Value	$-5M	$5M
Price	$1.27	$1.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.81x
EV/Sales	0.00x	14.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	1.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	205.5%
Profitability
Gross Margin (TTM)	0.0%	34.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-15M
FCF (TTM)	$-6M	$-15M
EPS (TTM)	-$1.76	-$2.82
ROE (TTM)	-12474.0%	-31490.0%
ROA (TTM)	-8749.0%	-13292.0%
ROIC (TTM)	-12474.0%	-22880.0%
Financial Health
Cash	$11M	$7M
Debt	$0	$7M
Net Cash/Debt	$11M	$-170K
Current Ratio (TTM)	3.88x	1.82x
Quick Ratio (TTM)	3.80x	1.44x
Debt/Equity (TTM)	0.00x	1.68x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	2.08
52W Performance	-84.3%	-79.7%
YTD Performance	-54.0%	-72.7%
% from 52W High	-84.4%	-80.0%
% from 52W Low	3.3%	12.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-113.2%	-334.7%
Earnings Yield (TTM)	-137.5%	-324.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View IMNN research

Valuation

P/S Ratio

ACXP

0.00x

IMNN

13.81x

EV/FCF

IMNN

-0.31x

ACXP

0.84x

Growth & revenue

Forward Revenue Growth

IMNN

205.5%

ACXP

40.7%

Profitability & performance

Gross Margin

IMNN

34.1%

ACXP

0.0%

ROE

ACXP

-12474.0%

IMNN

-31490.0%

FCF Yield %

ACXP

-113.2%

IMNN

-334.7%

52-Week Performance

IMNN

-79.7%

ACXP

-84.3%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

IMNN

Imunon Inc

Market Cap

ACXP$5M

IMNN$5M

Enterprise Value

ACXP$-5M

IMNN$5M

Price

ACXP$1.27

IMNN$1.08

P/E Ratio

ACXPN/A

IMNNN/A

P/S Ratio

ACXP0.00x

IMNN13.81x

EV/Sales

ACXP0.00x

IMNN14.14x

EV/EBITDA

ACXP0.00x

IMNN0.00x

P/B Ratio

ACXP0.87x

IMNN1.71x

P/FCF Ratio

ACXPN/A

IMNNN/A

EV/FCF

ACXP0.84x

IMNN-0.31x

PEG Ratio

ACXPN/A

IMNNN/A

Forward P/E (NTM)

ACXPN/A

IMNNN/A

Forward P/S (NTM)

ACXPN/A

IMNNN/A

Revenue (TTM)

ACXP$0

IMNN$0

Revenue Growth (YoY)

ACXPN/A

IMNNN/A

Forward Rev Growth

ACXP40.7%

IMNN205.5%

Gross Margin (TTM)

ACXP0.0%

IMNN34.1%

Operating Margin (TTM)

ACXP0.0%

IMNN0.0%

EBITDA Margin (TTM)

ACXP0.0%

IMNN0.0%

Net Margin (TTM)

ACXP0.0%

IMNN0.0%

FCF Margin (TTM)

ACXPN/A

IMNNN/A

Net Income (TTM)

ACXP$-8M

IMNN$-15M

FCF (TTM)

ACXP$-6M

IMNN$-15M

EPS (TTM)

ACXP-$1.76

IMNN-$2.82

ROE (TTM)

ACXP-12474.0%

IMNN-31490.0%

ROA (TTM)

ACXP-8749.0%

IMNN-13292.0%

ROIC (TTM)

ACXP-12474.0%

IMNN-22880.0%

Cash

ACXP$11M

IMNN$7M

Debt

ACXP$0

IMNN$7M

Net Cash/Debt

ACXP$11M

IMNN$-170K

Current Ratio (TTM)

ACXP3.88x

IMNN1.82x

Quick Ratio (TTM)

ACXP3.80x

IMNN1.44x

Debt/Equity (TTM)

ACXP0.00x

IMNN1.68x

Debt/Assets (TTM)

ACXP0.0%

IMNN0.0%

Interest Coverage (TTM)

ACXPN/A

IMNNN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

IMNN0.00x

Beta

ACXP-2.14

IMNN2.08

52W Performance

ACXP-84.3%

IMNN-79.7%

YTD Performance

ACXP-54.0%

IMNN-72.7%

% from 52W High

ACXP-84.4%

IMNN-80.0%

% from 52W Low

ACXP3.3%

IMNN12.5%

Asset Turnover (TTM)

ACXP0.00x

IMNN0.01x

FCF Yield (TTM)

ACXP-113.2%

IMNN-334.7%

Earnings Yield (TTM)

ACXP-137.5%

IMNN-324.8%

Dividend Yield (TTM)

ACXPN/A

IMNNN/A

Rule of 40

ACXP0.0

IMNN0.0

EV/GP/RG

ACXPN/A

IMNNN/A

Ticker research

View ACXP research View IMNN research

Metric	ACXP Acurx Pharmaceuticals Inc	IMNN Imunon Inc
Market & Valuation
Market Cap	$5M	$5M
Enterprise Value	$-5M	$5M
Price	$1.27	$1.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.81x
EV/Sales	0.00x	14.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	1.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	205.5%
Profitability
Gross Margin (TTM)	0.0%	34.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-15M
FCF (TTM)	$-6M	$-15M
EPS (TTM)	-$1.76	-$2.82
ROE (TTM)	-12474.0%	-31490.0%
ROA (TTM)	-8749.0%	-13292.0%
ROIC (TTM)	-12474.0%	-22880.0%
Financial Health
Cash	$11M	$7M
Debt	$0	$7M
Net Cash/Debt	$11M	$-170K
Current Ratio (TTM)	3.88x	1.82x
Quick Ratio (TTM)	3.80x	1.44x
Debt/Equity (TTM)	0.00x	1.68x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	2.08
52W Performance	-84.3%	-79.7%
YTD Performance	-54.0%	-72.7%
% from 52W High	-84.4%	-80.0%
% from 52W Low	3.3%	12.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-113.2%	-334.7%
Earnings Yield (TTM)	-137.5%	-324.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View IMNN research